These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12580679)

  • 1. Use of psychotropic medications in young, preschool children: primum non nocere.
    Barbaresi WJ
    Arch Pediatr Adolesc Med; 2003 Feb; 157(2):121-3. PubMed ID: 12580679
    [No Abstract]   [Full Text] [Related]  

  • 2. Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder.
    Rappley MD; Eneli IU; Mullan PB; Alvarez FJ; Wang J; Luo Z; Gardiner JC
    J Dev Behav Pediatr; 2002 Feb; 23(1):23-30. PubMed ID: 11889348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotropic drug use in very young children.
    Coyle JT
    JAMA; 2000 Feb; 283(8):1059-60. PubMed ID: 10697069
    [No Abstract]   [Full Text] [Related]  

  • 4. Annotation: The use of psychotropic medications in children: an American view.
    Wolraich ML
    J Child Psychol Psychiatry; 2003 Feb; 44(2):159-68. PubMed ID: 12587853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primum non nocere: balancing the risks and benefits of prescribing psychotropic medications for youth with bipolar disorder.
    DelBello MP; Correll CU
    Bipolar Disord; 2010 Mar; 12(2):113-5. PubMed ID: 20402705
    [No Abstract]   [Full Text] [Related]  

  • 6. Discussion on integrated pharmacologic treatment of attention-deficit hyperactivity disorder (ADHD).
    Hendren RL
    Essent Psychopharmacol; 2005; 6(5):291-300. PubMed ID: 16222913
    [No Abstract]   [Full Text] [Related]  

  • 7. Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder.
    Chen CY; Gerhard T; Winterstein AG
    J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):187-95. PubMed ID: 19364296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.
    Rappley MD; Mullan PB; Alvarez FJ; Eneli IU; Wang J; Gardiner JC
    Arch Pediatr Adolesc Med; 1999 Oct; 153(10):1039-45. PubMed ID: 10520611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic drug use among preschool children in the Medicaid program from 36 states.
    Garfield LD; Brown DS; Allaire BT; Ross RE; Nicol GE; Raghavan R
    Am J Public Health; 2015 Mar; 105(3):524-9. PubMed ID: 25602884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the prescribing of psychotropic medications to preschoolers.
    Zito JM; Safer DJ; dosReis S; Gardner JF; Boles M; Lynch F
    JAMA; 2000 Feb; 283(8):1025-30. PubMed ID: 10697062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
    Zito JM; Safer DJ; dosReis S; Magder LS; Gardner JF; Zarin DA
    Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1257-63. PubMed ID: 10591302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in Mental Health Diagnosis and Prescribing Across Pediatric Primary Care Practices.
    Mayne SL; Ross ME; Song L; McCarn B; Steffes J; Liu W; Margolis B; Azuine R; Gotlieb E; Grundmeier RW; Leslie LK; Localio R; Wasserman R; Fiks AG
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of medication in children with psychiatric disorders.
    Barton R
    Community Pract; 2007 Nov; 80(11):42, 44. PubMed ID: 18064853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnoses and psychotherapeutic medication treatment experiences of a cohort of children under 6 years old who received antipsychotic treatment in Florida's Medicaid program.
    Constantine RJ; Tandon R; McPherson M; Andel R
    J Child Adolesc Psychopharmacol; 2011 Feb; 21(1):79-84. PubMed ID: 21288122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic drug utilization in children with concurrent attention-deficit/hyperactivity disorder and anxiety.
    Liu X; Kubilis P; Xu D; Bussing R; Winterstein AG
    J Anxiety Disord; 2014 Aug; 28(6):530-6. PubMed ID: 24981018
    [No Abstract]   [Full Text] [Related]  

  • 17. Attention-deficit/hyperactivity disorder: diagnosis before treatment.
    Koplewicz HS
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):326. PubMed ID: 23083019
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
    Radigan M; Lannon P; Roohan P; Gesten F
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragile X syndrome and attention-deficit/hyperactivity disorder symptoms.
    Deshpande PS; Coffey DB
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):639-42. PubMed ID: 22196318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.